AF
AXSM icon

Advisornet Financial’s Axsome Therapeutics AXSM Stock Holding History

Advisornet Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Hold
123
– – ﹤0.01% 1273
2026
Q1 		$20.8K Buy
123
+18
+17% +$3.11K ﹤0.01% 1324
2025
Q4 		$19.2K Buy
105
+85
+425% +$11.9K ﹤0.01% 1336
2025
Q3 		$2.43K Buy
+20
New +$2.25K ﹤0.01% 1829

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Advisornet Financial's AXSM Position: Q2 2026 in Review

Advisornet Financial held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 123 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Advisornet Financial first reported a position in AXSM in Q3 2025 and has held it in 4 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Advisornet Financial held 123 shares of Axsome Therapeutics worth $30.1K as of Q2 2026.
  • Advisornet Financial left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1273 holding.
  • Advisornet Financial first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.